Clinical Trial Update: Study Evaluating Etanercept and Sulphasalazine in Ankylosing Spondylitis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating etanercept with sulfasalazine in ankylosing spondylitis has completed, and results were posted in November 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Etanercept (etanercept)
• Sulphasalazine (sulfasalazine)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Ankylosing Spondylitis | Phase 4 | Status: COMPLETED | Results posted: 2012-11-08